Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorambucil vs Fludarabine in Waldenström's Macroglobulinaemia and Splenic Lymphoma
NCT00608374Phase 3Completed
- Sponsor
- Taunton and Somerset NHS Foundation Trust
- Start
- Jun 2006
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of fludarabine in Waldenström macroglobulinemia (WM), splenic lymphoma with villous lymphocytes (SLVL), Lymphoplasmacytic Lymphoma (LPL), sponsored by Taunton and Somerset NHS Foundation Trust. Started Jun 2006; status: completed.
02
Drugs
fludarabine
03
Conditions
Waldenström macroglobulinemia (WM)splenic lymphoma with villous lymphocytes (SLVL)Lymphoplasmacytic Lymphoma (LPL)
Beyond the preview
Go deeper on NCT00608374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608374.